A Papadopoulou, M Alvanou, G Karavalakis… - …, 2023 - journals.lww.com
Adoptive immunotherapy with virus-specific cytotoxic T cells (VSTs) has evolved over the last three decades as a strategy to rapidly restore virus-specific immunity to prevent or treat …
Y Liang, Q Xu, S Liu, J Li, F Wang, Z Li, L Liao… - Frontiers in …, 2022 - frontiersin.org
T cell receptor-engineered T cells (TCR-Ts) have emerged as potent cancer immunotherapies. While most research focused on classical cytotoxic CD8+ T cells, the …
J Xiao, F Wang, X Hu, D Li, G Liu, Q Xu… - Advanced Materials …, 2023 - Wiley Online Library
Neoantigens derived from somatic mutations in cancer cells can induce antigen‐specific T‐ cell immune response for cancer immunotherapy. However, the 3D models for assessing …
Q Xu, Z Li, F Wang, Z Zhuang, Y Liang… - Journal of Cellular …, 2020 - scientificarchives.com
T cell-mediated immune response is essential for host defense against viruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which has caused a global …